Back to Capital International Investors Capital International Investors

CRSPCRSP
Showing 8 of 31 quarters

Position history for Capital International InvestorsCapital International Investors's holdings in CRISPR THERAPEUTICS AG

Yes. Capital International Investors holds 1,268,407 shares of CRSP (Crispr Therapeutics), worth $69.2M, as of its Q2 2026 13F filing. It increased the position by 81,613 shares (+6.9%) from Q1 2026. Capital International Investors has held CRSP in every 13F on record since Q4 2018, 31 quarterly filings.

Current Value

$69.2M

Current Shares

1.3M

Total Value Change

-$303.2M

Total Shares Change

-6.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.3M
+6.9%
$69.2M0.0%$54.54
32
2026-Q1
Decreased
1.2M
-79.9%
$56.5M0.0%$47.57
0
2025-Q4
Increased
5.9M
+4.3%
$309M0.0%$52.44
32
2025-Q3
Increased
5.6M
+1.0%
$366.1M0.1%$64.81
31
2025-Q2
Decreased
5.6M
-7.9%
$272.1M0.0%$48.64
0
2025-Q1
Decreased
6.1M
-30.5%
$206.7M0.0%$34.03
0
2024-Q4
Increased
8.7M
+10.3%
$344.1M0.1%$39.36
34
2024-Q3
Increased
7.9M
+0.8%
$372.4M0.1%$46.98
31

Other major holders of CRSP: ARK Investment Management LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used